Reaction
Nuclear Magnetic Resonance Imaging Brain Abnormal reporting signals
As of the last recalculation, Nuclear Magnetic Resonance Imaging Brain Abnormal appears in 1,453 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is TEMOZOLOMIDE (PRR 30.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Temozolomide | 43 | 30.1 | 30.2 |
| Vigabatrin | 29 | 29.1 | 29.1 |
| Thiotepa | 17 | 25.8 | 25.8 |
| Zidovudine | 20 | 21.7 | 21.7 |
| Metronidazole Topical | 58 | 18.1 | 18.1 |
| Metronidazole | 61 | 14.2 | 14.2 |
| Interferon Beta-1B | 14 | 10.6 | 10.6 |
| Extended Phenytoin Sodium | 12 | 10.4 | 10.4 |
| Lithium Carbonate | 12 | 10.2 | 10.2 |
| Mercaptopurine | 12 | 10.0 | 10.0 |
| Lamivudine | 19 | 8.9 | 8.9 |
| Cytarabine | 32 | 7.8 | 7.8 |
| Vincristine Sulfate | 15 | 7.4 | 7.4 |
| Interferon Beta-1A | 84 | 6.5 | 6.6 |
| Gefitinib | 4 | 6.4 | 6.4 |
| Pegaspargase | 5 | 5.9 | 5.9 |
| Natalizumab | 57 | 4.6 | 4.6 |